No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S 6.4x · 10Y median 7.0x · 33rd percentile · as of Sep 11, 2026
Annualized revenue (TTM) · by quarter, last 11
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-09-19T00:15:57.670Z. Latest historical point 2026-09-11. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
The latest delayed quote for Shoulder Innovations, Inc. (SI) stock was $18.16 as of Sep 18, 2026, 4:00 PM EDT, up 2.02% from the previous close.
Longer view (total return, dividends reinvested): past 12 months +23.6%
Shoulder Innovations, Inc. manufactures medical devices.
Medical - Specialties · Grand Rapids, MI
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
Next Earnings Date
N/A
EPS Estimate
N/A
Revenue Est.
N/A
Last Quarter Results
EPS
$-0.46
vs Estimate
$-0.45
Revenue
$17.18M
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1SI | $376.61M | $18.16 | +2.02% | +23.55% | N/A | N/A | N/A |
| 2NRC | $463.35M | $20.56 | -1.49% | +34.97% | -13.61% | +5.04% | vs SI |
| 3PDSB | $45.05M | $0.81 | -4.36% | -75.03% | -54.59% | -48.10% | vs SI |
| 4TDOC | $1.14B | $6.30 | +0.32% | -20.73% | -46.60% | -10.46% | vs SI |
| 5XRAY | $1.91B | $9.54 | +1.76% | -20.88% | -28.21% | -14.48% | vs SI |
| 6TMDX | $2.99B | $86.42 | -0.28% | -29.77% | +20.95% | N/A | vs SI |
N/A
vs Estimate
$15.47M
Consensus Rating
Based on 4 analysts
Average Price Target
$26.25
+44.5% upside
Low
$25.00
Current
$18.16
High
$28.00
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $-0.53 | $-0.51 | $-0.48 | 2 |
| Quarter ending Dec 2026 | $-0.49 | $-0.48 | $-0.45 | 2 |
| Quarter ending Mar 2027 | $-0.37 | $-0.36 | $-0.34 | 1 |
| Quarter ending Jun 2027 | $-0.46 | $-0.44 | $-0.42 | 1 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | $-1.92 | $-1.88 | $-1.85 | 2 |
| FY 2027 | $-1.60 | $-1.57 | $-1.55 | 2 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $14.88M | $15.47M | $15.95M | 2 |
| Quarter ending Dec 2026 | $18.37M | $19.09M | $19.69M | 2 |
| Quarter ending Mar 2027 | $20.24M | $21.03M | $21.68M | 1 |
| Quarter ending Jun 2027 | $21.11M | $21.94M | $22.62M | 1 |
Annual
| Period |
|---|
Source: FMP Analyst Consensus Estimates. Forward P/E is unavailable for the current price and estimate observations.
| Low |
|---|
| Avg |
|---|
| High |
|---|
| # Analysts |
|---|
| FY 2026 | $67.60M | $68.42M | $69.54M | 3 |
| FY 2027 | $87.34M | $88.40M | $89.84M | 3 |
